Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/10/1998 | CA2234411A1 Novel compounds |
12/09/1998 | EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene |
12/09/1998 | EP0882791A2 WNT-11 polypeptides |
12/09/1998 | EP0882736A1 LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
12/09/1998 | EP0882726A1 Carbazol-carboxamides as 5-HT1F agonists |
12/09/1998 | EP0882723A1 Thioxanthenone antitumor agents |
12/09/1998 | EP0882719A1 Arylethenesulfonamide derivatives and drug composition containing the same |
12/09/1998 | EP0882718A1 Benzimidazole derivatives |
12/09/1998 | EP0882717A1 Nitrogenous heterocyclic compounds |
12/09/1998 | EP0882707A1 Novel tricyclic compounds and drug compositions containing the same |
12/09/1998 | EP0882706A1 Cell adhesion inhibitors |
12/09/1998 | EP0882453A2 Methods for treating thrombotic disorders |
12/09/1998 | EP0882451A1 Glycine for prevention or treatment of transplant rejection |
12/09/1998 | EP0882450A2 Cholesterol-lowering composition comprising coenzyme Q |
12/09/1998 | EP0882228A1 Methods to identify modulators of cell signaling |
12/09/1998 | EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization |
12/09/1998 | EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
12/09/1998 | EP0882129A1 Recombinant expression of s-layer proteins |
12/09/1998 | EP0882128A1 Cell-based assay |
12/09/1998 | EP0882067A2 Methods of treating vascular disease with tnf antagonists |
12/09/1998 | EP0882066A1 Peptide derivatives |
12/09/1998 | EP0882065A2 Novel human metabotropic glutamate receptor |
12/09/1998 | EP0882063A2 Antifungic and antibacterial peptide |
12/09/1998 | EP0882060A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
12/09/1998 | EP0882058A1 Novel nucleoside derivatives and process for preparing the same |
12/09/1998 | EP0882052A1 New cephem compounds and pharmaceutical use thereof |
12/09/1998 | EP0882049A1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
12/09/1998 | EP0882048A1 3-methylimidazopyridines |
12/09/1998 | EP0882047A1 Quinolones and their therapeutic use |
12/09/1998 | EP0882046A1 Quinolones and their therapeutic use |
12/09/1998 | EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists |
12/09/1998 | EP0882042A1 Antibiotic oxazolidinone derivatives |
12/09/1998 | EP0882041A1 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents |
12/09/1998 | EP0882040A1 Antagonists of gonadotropin releasing hormone |
12/09/1998 | EP0882039A1 Endothelin receptor antagonists |
12/09/1998 | EP0882038A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
12/09/1998 | EP0882033A1 Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
12/09/1998 | EP0882031A1 Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines |
12/09/1998 | EP0882030A1 2,1,3-benzothia(oxa)diazole derivatives having an endothelin receptor antagonistic effect |
12/09/1998 | EP0882029A1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
12/09/1998 | EP0882024A1 Retroviral protease inhibiting compounds |
12/09/1998 | EP0882023A1 Histamine h 3 receptor ligands |
12/09/1998 | EP0882022A1 Aspartyl protease inhibitors |
12/09/1998 | EP0882021A1 New phenanthridines |
12/09/1998 | EP0882016A1 Alkylated styrenes as prodrugs to cox-2 inhibitors |
12/09/1998 | EP0882015A1 Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
12/09/1998 | EP0882010A1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology |
12/09/1998 | EP0881914A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
12/09/1998 | EP0881913A1 Liposomal-viral dna complexes for treating disease |
12/09/1998 | EP0881912A1 Use of angiogenic lipids for vascularizing tissue |
12/09/1998 | EP0881910A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
12/09/1998 | EP0881906A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
12/09/1998 | EP0881904A2 Topical pharmaceutical composition containing heparin |
12/09/1998 | EP0881903A1 Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid |
12/09/1998 | EP0881902A1 Combinations of peroxide lipids and organosilicon compounds, cosmetic and dermatological compositions containing same, and uses thereof, in particular for treating alopecia |
12/09/1998 | EP0881901A1 New associations of active principles containing clopidogrel and an antithrombotic agent |
12/09/1998 | EP0881900A1 Use of leukotriene b 4? or its analogues as antiviral and antineoplastic agents |
12/09/1998 | EP0881899A2 Dosage form of ibuprofen |
12/09/1998 | EP0881897A1 Composition and method for effecting superficial chemical skin peels |
12/09/1998 | EP0881896A1 Skin treatment with salicylic acid esters and retinoids |
12/09/1998 | EP0881891A1 Male contraceptive implant |
12/09/1998 | EP0881881A1 Antiparasitic composition for treating and protecting pets |
12/09/1998 | EP0862438A4 Use of sphingosylphosphorylcholine as a wound-healing agent |
12/09/1998 | EP0810866A4 Use of acid-sensitive organo- transition metal compounds in cancer treatment |
12/09/1998 | EP0771188B1 Soap composition |
12/09/1998 | EP0745089B1 Antiparasitic agents |
12/09/1998 | EP0719251B1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists |
12/09/1998 | EP0716605B1 Blocking the accumulation of germs on human cells |
12/09/1998 | EP0712390B1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
12/09/1998 | EP0636028A4 Self-assembling polynucleotide delivery system. |
12/09/1998 | EP0628052B1 Alkali metal 8,9-dehydroestrone sulfate esters |
12/09/1998 | EP0332667B2 Vector for integration site independent gene expression in mammalian host cells |
12/09/1998 | CN1201463A Novel nucleoside derivatives and process for preparing same |
12/09/1998 | CN1201461A Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
12/09/1998 | CN1201460A One pot synthesis of 2-oxazolidinone derivatives |
12/09/1998 | CN1201459A Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
12/09/1998 | CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
12/09/1998 | CN1201455A Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy] ethylamino)-3-phenoxy-2(S)-ol |
12/09/1998 | CN1201454A Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
12/09/1998 | CN1201453A 4-(cycloalkyl) piperidine and 4-(cycloalkylalkyl) piperidine derivatives, preparation thereof and application in medicines |
12/09/1998 | CN1201452A 24-homo-26,27-hexafluoro-choleccalciferols |
12/09/1998 | CN1201447A Butyrate prodrugs of lactic acid |
12/09/1998 | CN1201397A Improved prescription for steroid compound administration |
12/09/1998 | CN1201395A Method for treatment of helicobacter pylori infections |
12/09/1998 | CN1201393A Compositions and methods for treating bone deficit conditions |
12/09/1998 | CN1201392A Pentacyclic compounds, intermediates, preparation process, compositions and methods thereof |
12/09/1998 | CN1201391A Use of flupirtin for prevention and treatment of disease which are associated with damage to haemopoietic cell system |
12/09/1998 | CN1201390A 5-HT3 receptor antagonists for treating dyskinesia |
12/09/1998 | CN1201389A Method and pharmaceutical composition for regulating lipid concentration |
12/09/1998 | CN1201388A Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans |
12/09/1998 | CN1201387A Lyophilized thioxanthenone anti-tumor angents |
12/09/1998 | CN1201385A Therapeutic preparation for transdermal administration of active substances |
12/09/1998 | CN1201384A Aerosol compositions |
12/09/1998 | CN1201369A Stimulation of cell-mediated immune responses by targeted particulated genetic immunization |
12/09/1998 | CN1201038A Sulfurization for oestrogen mixture |
12/09/1998 | CN1201037A 5'-deoxy-cytidine derivatives |
12/09/1998 | CN1201033A Solid chemical compound, preparation method therefor and use in medicine |
12/09/1998 | CN1200925A Medicine composition for treating drug-resistant malignant malaria and preparation method therefor |
12/09/1998 | CN1200924A Fluoxetine enteric micropills |
12/09/1998 | CN1200922A Method for scavenging free radical by orange extracted liquor |